The estimated Net Worth of Joey A Jacobs is at least $49.3 Million dollars as of 10 May 2019. Mr. Jacobs owns over 6,695 units of Cumberland Pharmaceuticals stock worth over $119,369 and over the last 14 years he sold CPIX stock worth over $49,180,904. In addition, he makes $0 as Independent Director at Cumberland Pharmaceuticals.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Jacobs CPIX stock SEC Form 4 insiders trading
Joey has made over 15 trades of the Cumberland Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 6,695 units of CPIX stock worth $41,978 on 10 May 2019.
The largest trade he's ever made was selling 500,000 units of Cumberland Pharmaceuticals stock on 22 August 2017 worth over $25,345,000. On average, Joey trades about 21,073 units every 50 days since 2011. As of 10 May 2019 he still owns at least 88,415 units of Cumberland Pharmaceuticals stock.
You can see the complete history of Mr. Jacobs stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joey Jacobs biography
Joey A. Jacobs serves as Independent Director of the Company. He joined Cumberland’s Board of Directors in 2011 and is Chairman of our Governance and Nominating Committee and Lead Independent Director. A healthcare veteran with more than 44 years of industry experience, Mr. Jacobs is the former Chairman and Chief Executive Officer of Acadia Healthcare, a rapidly growing behavioral health company. Mr. Jacobs is the former Chairman, President and Chief Executive Officer of Nashville-based Psychiatric Solutions, Inc. (PSI), which he co-founded in 1997 and grew into a $2 billion behavioral healthcare system before the company’s sale to Universal Health Services in 2010. Prior to founding PSI, Mr. Jacobs spent 21 years at Hospital Corporation of America, or HCA, where he served in various capacities. In addition to serving as the former Chairman of the Nashville Health Care Council, he is also a past director of the Federation of American Hospitals, the National Association of Psychiatric Health Systems, Mental Health Management and Envision Corporation. He is currently a board member of the Monroe Carell, Jr. Children’s Hospital at Vanderbilt and Middle Tennesse State University. Mr. Jacobs holds a B.S. degree from Middle Tennessee State University. The Board of Directors believes Mr. Jacobs’ extensive hospital industry experience as well as his experience as chairman and CEO of two publicly traded healthcare companies will be critical as the Company continues to develop its hospital acute care product line and navigate the responsibilities associated with being a public company.
How old is Joey Jacobs?
Joey Jacobs is 66, he's been the Independent Director of Cumberland Pharmaceuticals since 2011. There are 8 older and 10 younger executives at Cumberland Pharmaceuticals. The oldest executive at Cumberland Pharmaceuticals Inc. is Jonathan Griggs, 85, who is the Independent Director.
What's Joey Jacobs's mailing address?
Joey's mailing address filed with the SEC is 1600 WEST END AVENUE, SUITE 1300, NASHVILLE, TN, 37203.
Insiders trading at Cumberland Pharmaceuticals
Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv, and Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.
What does Cumberland Pharmaceuticals do?
cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
What does Cumberland Pharmaceuticals's logo look like?
Complete history of Mr. Jacobs stock trades at Acadia Healthcare Inc and Cumberland Pharmaceuticals
Cumberland Pharmaceuticals executives and stock owners
Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include:
-
A. Kazimi,
Chairman of the Board, Chief Executive Officer -
A. J. Kazimi,
Founder, Chairman, Pres & CEO -
Leo Pavliv,
Executive Vice President - Operations, Chief Development Officer -
Leo B. Pavliv,
Exec. VP of Operations & Chief Devel. Officer -
Martin Cearnal,
Executive Vice President, Chief Commercial Officer, Director -
Martin E. Cearnal,
Exec. VP, Chief Commercial Officer & Director -
James Herman,
Vice President - National Accounts, Chief Compliance Officer -
James Lowrance Herman,
Sr. VP of National Accounts & Chief Compliance Officer -
Michael Bonner,
Senior Director Finance and Accounting and Chief Financial Officer -
Caroline Young,
Independent Director -
Kenneth Krogulski,
Independent Director -
James Jones,
Independent Director -
Joey Jacobs,
Independent Director -
Jonathan Griggs,
Independent Director -
Joseph Galante,
Independent Director -
Gordon Bernard,
Independent Director -
Erin Smith Gull,
Sr. Corp. Relations Associate -
Adam S. Mostafa,
Managing Director -
Cindy B. Patton,
Sr. Director of Field Marketing -
Jean W. Marstiller,
Sr. VP of Admin. Services & Corp. Sec. -
John Michael Hamm,
Director of Fin. & Accounting and CFO -
Thomas R Lawrence,
Director -
Martin S Jr Brown,
-
Chris T. Bitterman,
Vice Pres Sales & Marketing -
Rick Scott Greene,
Chief Financial Officer -
Robert Edwards,
Director -
Jean W Marstiller,
Sr. VP & Corp. Secretary -
Lawrence W Greer,
Director -
David L Lowrance,
Vice President and CFO -
Todd M. Anthony,
Vice Pres Organizational Dev -
John M. Hamm,
VP Chief Financial Officer